Results 161 to 170 of about 38,544 (277)

Docking, Synthesis and Biological Evaluation of NovelDiketoquinoline Analogues as HIV-1 Integrase Inhibitor

, 2019
Kishore D. Deo, I.J. Singhvi, Sachin Patil, Avinash V. Patil   +3 more
openalex   +1 more source

CoMFA and CoMSIA Studies on Inhibitors of HIV‐1 Integrase ‐ Bicyclic Pyrimidinones [PDF]

, 2010
V. Radhika, Sivan Sree Kanth, M. Vijjulatha   +2 more
openalex   +1 more source

Oestradiol concentrations in trans women with HIV suppressed on unboosted integrase inhibitor regimens versus trans women without HIV taking oral oestradiol: a pilot study. [PDF]

J Antimicrob Chemother, 2023
Loutfy M, Lacombe-Duncan A, Tseng A, Persad Y, Underhill A, Kennedy VL, Armstrong I, Fung R, Bourns A, Nguyen Q, Hranilovic S, Weisdorf T, Chan LYL, Kia H, Halpenny R, Iyer H, Jeyarajah N, Kovchazov G, McCully J, Scarsi KK.   +19 more
europepmc   +1 more source

Unmasking Mycobacterium avium: two case reports of cutaneous lesions in HIV patients after initiation of an integrase inhibitor-based regimen. [PDF]

BMC Infect Dis
Camero L, Soto LM, Flora-Noda DM, Becerra-Vivas LL, Guerra-Martínez A, España M, Claro FE, de Waard JH, Silva D, Carrión-Nessi FS, Forero-Peña DA.   +10 more
europepmc   +1 more source

Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor. [PDF]

ACS Med Chem Lett, 2022
Parcella K, Parcella K, Wang T, Eastman K, Zhang Z, Yin Z, Patel M, Tu Y, Zheng BZ, Walker MA, Saulnier MG, Frennesson D, Bowsher M, Gillis E, Peese K, Belema M, Cianci C, Dicker IB, McAuliffe B, Ding B, Falk P, Simmermacher J, Parker DD, Sivaprakasam P, Kish K, Lewis H, Hanumegowda U, Jenkins S, Kadow JF, Krystal M, Meanwell NA, Naidu BN.   +31 more
europepmc   +1 more source

Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitors [PDF]

, 2018
Ronit R. Dalmat, Negar Makhsous, Gregory Pepper, Amalia Magaret, Keith R. Jerome, Anna Wald, Alexander L. Greninger   +6 more
openalex   +1 more source

Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy. [PDF]

PLoS One
Blanco JR, Torralba M, Saumoy M, Alcaraz A, Del Amo MM, Olalla J, Dronda F, Boukichou-Abdelkader N, Bernal E, Padilla S, Peraire J, Artigues F, Bustinduy-Odriozola MJ, Iglesias HA, Delgado A, Imaz A, Pérez-Martinez L, Cohort CIS.   +17 more
europepmc   +1 more source

Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy. [PDF]

AIDS, 2022
Vakili S, Paneru B, Guerrier CM, Miller J, Baumrin E, Forrestel A, Lynn K, Frank I, Lo Re V, Collman RG, Hill DA.   +10 more
europepmc   +1 more source

Feasibility of Switching to an Integrase Inhibitor-Based Single-Tablet Regimen in Adults Living With HIV and Sustained Virological Suppression on Outdated Antiretroviral Therapies. [PDF]

Cureus
Tiecco G, Alberti M, Salvi M, Scarvaglieri I, Cesanelli F, Focà E, Castelli F, Quiros-Roldan E.   +7 more
europepmc   +1 more source

High Baseline Viremia: An Achilles Heel for Integrase Inhibitor-Based Antiretroviral Therapy? [PDF]

Clin Infect Dis, 2021
McCluskey SM, Marconi VC.
europepmc   +1 more source